Strides Pharma Science Share Price
- Advice
- Hold
Start SIP in Strides Pharma Science
Start SIPStrides Pharma Science Performance
Day Range
- Low 1,355
- High 1,407
52 Week Range
- Low 467
- High 1,431
- Open Price1,401
- Previous Close1,395
- Volume257831
Strides Pharma Science Investment Rating
-
Master Rating:
-
Strides Pharma Science has an operating revenue of Rs. 4,208.64 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 1% needs improvement, ROE of -3% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 20% and 60% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 40% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of A is the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 555 | 618 | 520 | 540 | 475 | 564 |
| Operating Expenses Qtr Cr | 494 | 527 | 454 | 497 | 420 | 444 |
| Operating Profit Qtr Cr | 61 | 91 | 66 | 43 | 56 | 119 |
| Depreciation Qtr Cr | 20 | 21 | 21 | 21 | 21 | 23 |
| Interest Qtr Cr | 47 | 47 | 44 | 40 | 37 | 43 |
| Tax Qtr Cr | 2 | -1 | 1 | 3 | 1 | 3 |
| Net Profit Qtr Cr | 4 | 54 | 3 | 1 | 8 | 62 |
Strides Pharma Science Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹1,322.12
- 50 Day
- ₹1,204.77
- 100 Day
- ₹1,075.65
- 200 Day
- ₹915.06
- 20 Day
- ₹1,340.40
- 50 Day
- ₹1,167.94
- 100 Day
- ₹1,031.04
- 200 Day
- ₹875.61
Strides Pharma Science Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1,411.65 |
| Second Resistance | 1,435.05 |
| Third Resistance | 1,463.55 |
| RSI | 67.79 |
| MFI | 70.59 |
| MACD Single Line | 61.78 |
| MACD | 55.23 |
| Support | |
|---|---|
| First Support | 1,359.75 |
| Second Support | 1,331.25 |
| Third Supoort | 1,307.85 |
Strides Pharma Science Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 271,218 | 14,621,362 | 53.91 |
| Week | 296,799 | 17,089,675 | 57.58 |
| 1 Month | 372,091 | 20,904,072 | 56.18 |
| 6 Month | 403,514 | 19,235,496 | 47.67 |
Strides Pharma Science Result Highlights
Strides Pharma Science Synopsis
NSE-Medical-Generic Drugs
Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1854.50 Cr. and Equity Capital is Rs. 90.30 Cr. for the Year ended 31/03/2023. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.| Market Cap | 12,766 |
| Sales | 2,233 |
| Shares in Float | 6.80 |
| No of funds | 199 |
| Yield | 0.29 |
| Book Value | 3.58 |
| U/D Vol ratio | 2.8 |
| LTDebt / Equity | 6 |
| Alpha | 0.35 |
| Beta | 0.79 |
Strides Pharma Science Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 25.86% | 25.88% | 27.39% | 27.78% |
| Mutual Funds | 10.5% | 10.57% | 13.09% | 13.67% |
| Insurance Companies | 6.16% | 5.77% | 4.46% | 4.54% |
| Foreign Portfolio Investors | 26.71% | 24.57% | 19.45% | 17.25% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 20.87% | 21.19% | 22.64% | 23.39% |
| Others | 9.89% | 12.01% | 12.96% | 13.36% |
Strides Pharma Science Management
| Name | Designation |
|---|---|
| Mr. Arun Kumar | Exe.Chairman & Mng.Director |
| Mr. Badree Komandur | Executive Director & Group CFO |
| Dr. Kausalya Santhanam | Independent Director |
| Mr. Bharat D Shah | Independent Director |
| Mr. Homi Rustam Khusrokhan | Independent Director |
| Mr. S Sridhar | Independent Director |
Strides Pharma Science Forecast
Price Estimates
Strides Pharma Science Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-29 | Quarterly Results | |
| 2024-05-22 | Audited Results & Final Dividend | |
| 2024-01-30 | Quarterly Results | |
| 2023-10-30 | Quarterly Results | |
| 2023-09-25 | Scheme of Arrangement |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-09-09 | FINAL | Rs.2.50 per share(25%)Final Dividend |
| 2023-08-04 | FINAL | Rs.1.50 per share(15%)Final Dividend |
| 2021-08-06 | FINAL | Rs.2.50 per share(25%)Final Dividend |
Strides Pharma Science FAQs
What is Share Price of Strides Pharma Science ?
Strides Pharma Science share price is ₹1,388 As on 18 September, 2024 | 02:29
What is the Market Cap of Strides Pharma Science ?
The Market Cap of Strides Pharma Science is ₹12766.1 Cr As on 18 September, 2024 | 02:29
What is the P/E ratio of Strides Pharma Science ?
The P/E ratio of Strides Pharma Science is 1905.1 As on 18 September, 2024 | 02:29
What is the PB ratio of Strides Pharma Science ?
The PB ratio of Strides Pharma Science is 6.2 As on 18 September, 2024 | 02:29